U.S. Health Care REITs Stock News

On May 12, 2026, Akso Health Group’s audit committee dismissed Onestop Assurance PAC as its independent registered public accounting firm and appointed CHI-LLTC as the new auditor, effective immediately. This change in external auditor highlights a meaningful shift in Akso Health Group’s approach to financial oversight and corporate governance transparency. We will now examine how the shift from Onestop Assurance PAC to CHI-LLTC may influence Akso Health Group’s investment narrative. Invest...

It looks like Brookfield Infrastructure Corporation ( NYSE:BIPC ) is about to go ex-dividend in the next 4 days. The...

It's been a good week for Vipshop Holdings Limited ( NYSE:VIPS ) shareholders, because the company has just released...

NervGen Pharma (NGEN) has drawn fresh attention after completing a follow on public equity offering of approximately $60 million, including common shares and warrants, to fund its neuroreparative drug development programs. See our latest analysis for NervGen Pharma. The follow on offering has coincided with sharp share price pressure, with NervGen Pharma’s 1 day share price return down 43.48% and its year to date share price return down 64.63%. This comes even though the 5 year total...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Expedia...

It looks like Copa Holdings, S.A. ( NYSE:CPA ) is about to go ex-dividend in the next 4 days. Typically, the...

It looks like First National Corporation ( NASDAQ:FXNC ) is about to go ex-dividend in the next 4 days. Typically, the...

Teekay (TK) has moved back onto investor radars after reporting first quarter 2026 sales of US$286.09 million and net income of US$153.55 million, alongside a US$1.00 per share special dividend announcement. See our latest analysis for Teekay. The recent special dividend and first quarter earnings update come after a period of strong momentum, with a year to date share price return of 51.25% and a 1 year total shareholder return of 82.14%, suggesting improving sentiment around Teekay’s...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

It looks like Evercore Inc. ( NYSE:EVR ) is about to go ex-dividend in the next 4 days. The ex-dividend date is usually...

It looks like AngloGold Ashanti plc ( NYSE:AU ) is about to go ex-dividend in the next four days. The ex-dividend date...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see JAKKS...

It's been a pretty great week for Ralph Lauren Corporation ( NYSE:RL ) shareholders, with its shares surging 16% to...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

Mativ Holdings, Inc. ( NYSE:MATV ) stock is about to trade ex-dividend in four days. Typically, the ex-dividend date is...

Union Pacific Corporation ( NYSE:UNP ) is about to trade ex-dividend in the next four days. The ex-dividend date occurs...

Just because a business does not make any money, does not mean that the stock will go down. For example, although...

Readers hoping to buy T-Mobile US, Inc. ( NASDAQ:TMUS ) for its dividend will need to make their move shortly, as the...

Despite the fact that Chaince Digital Holdings Inc.'s (NASDAQ:CD) value has dropped 11% in the last week insiders who...

Ross Stores, Inc. ( NASDAQ:ROST ) just released its quarterly report and things are looking bullish. Ross Stores beat...

LuxExperience B.V (LUXE) drew fresh attention after reporting third quarter and nine month results that paired higher sales with a wider net loss, while also closing the sale of THE OUTNET and outlining a YNAP transformation plan. See our latest analysis for LuxExperience B.V. The latest quarter, with higher sales but a wider loss and fresh restructuring charges, has coincided with pressure on the stock, which is down 21.31% on a 1 month share price basis and 22.53% on a 1 year total...

Earlier in May 2026, Nvidia invested US$10.40 million in Generate Biomedicines, an AI-driven biotech now advancing several drug candidates through clinical development, including a Phase 3 severe asthma program and oncology therapies with FDA Fast Track status. This combination of external validation from a major AI leader and visible clinical momentum underscores how AI-enabled drug discovery is moving from concept toward real-world testing. Next, we’ll examine how Nvidia’s investment and...